Mar-Cof CG Shortage Update: What Patients Need to Know in 2026

If you've had trouble filling a Mar-Cof CG prescription in 2026, you're likely wondering: is there a shortage? Is this a national problem or just bad luck at my local pharmacy? Here's what the current data shows and what it means for you.

Is Mar-Cof CG on the FDA Shortage List in 2026?

As of 2026, Mar-Cof CG does not appear on the FDA's official Drug Shortage Database as an active shortage. The FDA shortage list is specifically for drugs where there is a national supply disruption — typically due to manufacturing issues, raw material problems, or distribution failures affecting the entire supply chain.

This means Mar-Cof CG is not in the same category as drugs like amoxicillin, Adderall, or injectable medications that have experienced well-publicized national shortages in recent years.

So Why Is Mar-Cof CG Hard to Find?

The challenges patients face finding Mar-Cof CG are real — they're just driven by different factors than a traditional drug shortage. Here are the key contributors:

• Controlled substance stocking gaps. As a Schedule V controlled substance, Mar-Cof CG requires pharmacies to maintain DEA compliance records. Many pharmacies — particularly smaller independent locations — choose not to stock it because the administrative burden outweighs the demand.
• Declining overall demand. The availability of highly effective OTC alternatives (like Delsym and Mucinex) and prescription non-opioid options (like benzonatate) has reduced the number of patients prescribed codeine cough syrups over the past decade. Lower demand means fewer pharmacies stock it and in smaller quantities.
• Small manufacturer distribution. Mar-Cof CG is produced by Marnel Pharmaceuticals, a smaller pharmaceutical company without the national distribution reach of major brands like Johnson & Johnson or Pfizer. This can create regional gaps in availability.
• Seasonal demand spikes. During peak cold and flu season (typically October through March), demand for all cough products — including codeine syrups — increases. Pharmacies that maintain minimal inventory may run out more frequently during these periods.

Historical Context: Has Mar-Cof CG Had Shortages Before?

Mar-Cof CG has not been listed in the FDA shortage database historically as a major shortage drug. Unlike some other drug categories, codeine-guaifenesin products don't rely on complex sterile manufacturing or single-source APIs that make drugs like injectable chemotherapy agents prone to shortage.

The broader context: codeine-containing products have faced increasing regulatory scrutiny since the FDA issued its 2018 recommendation against using codeine in patients under 18. This led many manufacturers and pharmacies to reduce their codeine product lines, which did reduce overall supply somewhat — but not to shortage levels for adults who need it.

What to Do If Your Pharmacy Is Out of Mar-Cof CG

Even though there's no national shortage, individual pharmacies can and do run out of Mar-Cof CG. Here's your action plan:

1. Check nearby pharmacies using medfinder. Rather than calling each pharmacy yourself, use medfinder.com to have multiple pharmacies checked simultaneously. Results are texted to you.
2. Ask your pharmacy to reorder. If they carry it but are out of stock, most pharmacies can special-order it within 1–3 business days.
3. Ask about the generic. Generic codeine phosphate/guaifenesin oral solution may be available when the Mar-Cof CG brand is not.
4. Consider an alternative. If Mar-Cof CG remains unavailable, ask your doctor about alternatives such as benzonatate or dextromethorphan. See our full Mar-Cof CG alternatives guide for details.

Should You Stockpile Mar-Cof CG?

No. Because Mar-Cof CG contains codeine, a Schedule V controlled substance, stockpiling is not advisable and could raise red flags with your pharmacy or prescriber. Additionally, codeine-containing products are meant for short-term use only. Storing large quantities also increases the risk of misuse or accidental ingestion by children or other household members.

The better approach is to know how to quickly locate it when you need it — which is exactly what tools like medfinder are designed to help with.

The 2026 Summary: No National Shortage, But Still Worth Planning Ahead

Mar-Cof CG is not in an active national shortage in 2026. However, its controlled substance status, small manufacturer footprint, and reduced pharmacy stocking mean you should plan to check availability before you actually need it. medfinder.com makes that check fast and easy — so you're never caught without your prescription when you need it most.